Liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia
August 14 2017
In a multicenter, randomized, double-blind, placebo-controlled trial, Cornely et al. showed that liposomal amphotericin B (L-AMB) was not effective as prophylaxis against invasive fungal disease (IFD) in patients with newly diagnosed acute lymphoblastic leukaemia (ALL).
Coccidioidomycosis (Valley fever) missed as a cause of death in the USA
August 09 2017
About 150,000 annual cases of coccidioidomycosis occur each year in the USA (especially in Arizona), and at least as many in Central and South America, of which about ~40% are symptomatic and clinically apparent.
Call for global action on life-threatening fungal infections
August 01 2017
A ‘first of its kind’ series comprising of eight new authoritative papers has been published today in the prestigious journal The Lancet Infectious Diseases. The series gives new insights into the breadth of fungal diseases and a call to action for world health bodies to prevent millions of infections each year.
Two new species of thermally dimorphic yeast-like fungi has been described.
July 31 2017
Two new species, Emergomyces africanus from the newly created genus Emergomyces and Blastomyces percursus from the existing genus Blastomyces have recently been described.
Invasive mold infections in Thailand, Taiwan, India, China and Singapore
July 27 2017
Invasive mould infection (IMI) is a term for a large spectrum of emerging invasive diseases such as aspergillosis, zygomycosis, phaeohyphomycosis, or other mould infections. A recent study of the epidemiological and clinical characteristics of 155 IMI cases among Asian patients (Thailand, Taiwan, India, China and Singapore) has just been published by Dr Porpon Rotjanapan from Ramathibodi Hospital, Bangkok, Thailand and colleagues. In retrospective data from 2012 of 155 IMI cases found an incidence rate between 0.024 and 0.236 per 1,000 patient-days in hospital.